CN101365494A - 治疗自身免疫性疾病的组合物和方法 - Google Patents

治疗自身免疫性疾病的组合物和方法 Download PDF

Info

Publication number
CN101365494A
CN101365494A CNA2006800456906A CN200680045690A CN101365494A CN 101365494 A CN101365494 A CN 101365494A CN A2006800456906 A CNA2006800456906 A CN A2006800456906A CN 200680045690 A CN200680045690 A CN 200680045690A CN 101365494 A CN101365494 A CN 101365494A
Authority
CN
China
Prior art keywords
self
vector
polypeptide
secreted
intron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800456906A
Other languages
English (en)
Chinese (zh)
Inventor
内尼特·苏瓦山
迈克尔·勒维腾
海德基·葛元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayhill Therapeutics Inc
Original Assignee
Bayhill Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayhill Therapeutics Inc filed Critical Bayhill Therapeutics Inc
Publication of CN101365494A publication Critical patent/CN101365494A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CNA2006800456906A 2005-10-05 2006-10-04 治疗自身免疫性疾病的组合物和方法 Pending CN101365494A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72420305P 2005-10-05 2005-10-05
US60/724,203 2005-10-05

Publications (1)

Publication Number Publication Date
CN101365494A true CN101365494A (zh) 2009-02-11

Family

ID=37943343

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800456906A Pending CN101365494A (zh) 2005-10-05 2006-10-04 治疗自身免疫性疾病的组合物和方法

Country Status (9)

Country Link
US (1) US20100160415A1 (enExample)
EP (1) EP1931390B1 (enExample)
JP (1) JP2009511014A (enExample)
CN (1) CN101365494A (enExample)
AU (1) AU2006302477A1 (enExample)
CA (1) CA2624615A1 (enExample)
IL (1) IL190520A0 (enExample)
NZ (1) NZ567150A (enExample)
WO (1) WO2007044394A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1668105T3 (pl) * 2003-09-29 2019-03-29 Deb Ip Limited Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
CN101170904A (zh) 2005-03-07 2008-04-30 戴博全球保健有限公司 含有有机硅基表面活性剂的高醇含量发泡组合物
US20180092991A1 (en) * 2009-06-05 2018-04-05 Bayhill Therapeutics, Inc. Compositions and methods for treatment of insulin-dependent diabetes mellitus
EP2525825A1 (en) * 2010-01-20 2012-11-28 Bayhill Therapeutics, Inc. Combination therapy to treat autoimmune diseases
US9222107B2 (en) 2011-05-25 2015-12-29 National University Corporation Okayama University REIC-expressing adenovirus vector
KR101466874B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 자가면역 질환의 예방과 치료를 위한 ｉｌ-６ 수용체에 대한 항체를 발현하는 미니서클
KR101466875B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료
ES2719691T3 (es) 2013-11-22 2019-07-12 Amarna Holding B V Procedimiento de restauración de tolerancia inmunitaria in vivo
US20160320384A1 (en) * 2013-12-31 2016-11-03 Yeda Research And Development Co. Ltd. Methods for assaying immunological competence
EP3090064B1 (en) 2013-12-31 2019-11-13 Yeda Research and Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
US20170196949A1 (en) * 2014-06-04 2017-07-13 Diamyd Medical Ab Novel combinations for antigen based therapy
WO2016139659A1 (en) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
NZ749593A (en) * 2016-06-20 2025-10-31 Univ Leland Stanford Junior Circular rnas and their use in immunomodulation
HUE051766T2 (hu) 2016-11-01 2021-03-29 Novo Nordisk As Tolerogén DNS vakcina
US20210277417A1 (en) * 2018-06-25 2021-09-09 Akouos, Inc. Methods of treating clrn1-associated hearing loss and/or vision loss
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
JP2002520299A (ja) * 1998-07-09 2002-07-09 メルク エンド カムパニー インコーポレーテッド ポリヌクレオチドワクチン配合物
MXPA01007895A (es) * 1999-02-03 2003-07-21 Biosante Pharmaceuticals Inc Particulas terapeuticas de fosfato de calcio, metodos de manufactura y usos.
US7030098B2 (en) * 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2456821A1 (en) * 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
EP2301553A1 (en) * 2001-11-21 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Polynucleotide therapy
US20040002537A1 (en) * 2002-03-29 2004-01-01 Zamvil Scott S. Use of statins in the treatment of autoimmune disease
ES2457022T3 (es) * 2003-10-10 2014-04-24 Powderject Vaccines, Inc. Construcciones de ácidos nucleicos

Also Published As

Publication number Publication date
EP1931390A4 (en) 2009-04-15
EP1931390B1 (en) 2012-07-25
WO2007044394A3 (en) 2007-07-12
US20100160415A1 (en) 2010-06-24
IL190520A0 (en) 2008-11-03
WO2007044394A2 (en) 2007-04-19
CA2624615A1 (en) 2007-04-19
AU2006302477A1 (en) 2007-04-19
EP1931390A2 (en) 2008-06-18
NZ567150A (en) 2011-12-22
JP2009511014A (ja) 2009-03-19

Similar Documents

Publication Publication Date Title
US7544669B2 (en) Polynucleotide therapy
CN101365494A (zh) 治疗自身免疫性疾病的组合物和方法
US20100048679A1 (en) Polynucleotide therapy
CN101945666A (zh) 治疗自身免疫和过敏性疾病的组合物及方法
US20030229044A1 (en) Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
CN100546657C (zh) 预防和治疗疾病的方法及免疫调节核酸组合物
JP2009540016A (ja) 疾患を予防および処置するための方法および免疫調節核酸組成物
JP2013517329A (ja) 自己免疫疾患を処置するための併用治療
AU2008201186B2 (en) Polynucleotide therapy
US20180092991A1 (en) Compositions and methods for treatment of insulin-dependent diabetes mellitus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090211